Canada· CA-DIN-00493392
RIMSO-50
A dimethyl sulfoxide product containing dimethyl sulfoxide, registered in Canada by MYLAN PHARMACEUTICALS ULC. The same ATC class is registered in 4 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Dimethyl sulfoxide is registered in 4 of 19 countries.
Countries holding a registration under ATC G04BX13 (dimethyl sulfoxide), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 2 of them publish a price we can compare per daily dose
Dimethyl sulfoxide · ATC G04BX13
4 / 19 countries
- Canada
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- DIMETHYL SULFOXIDE
- Manufacturer
- MYLAN PHARMACEUTICALS ULC
- Country
- Canada (CA)
- ATC code
- G04BX13
- ATC class
- Dimethyl sulfoxide
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dimethyl sulfoxide in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomRimso-50 solution for instillationThornton & Ross Ltd
- United StatesDimethyl SulfoxideRenova Pharmaceuticals LLC
- Japanジメチルスルホキシド杏林製薬
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Latvia · Osteogēls
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/98635f3c-403e-4b85-9af9-cf7d514e50fd GET /v1/drugs/98635f3c-403e-4b85-9af9-cf7d514e50fd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00493392",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVESICAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "G04BX13",
"schedule": [
"Prescription"
],
"drug_code": "3769",
"strengths": [
"500 MG"
],
"ahfs_class": null,
"substances": [
"DIMETHYL SULFOXIDE"
],
"product_categorization": null
}See everything about dimethyl sulfoxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.